208 related articles for article (PubMed ID: 28396035)
1. Vancomycin-intermediate Staphylococcus aureus isolates are attenuated for virulence when compared with susceptible progenitors.
Cameron DR; Lin YH; Trouillet-Assant S; Tafani V; Kostoulias X; Mouhtouris E; Skinner N; Visvanathan K; Baines SL; Howden B; Monk IR; Laurent F; Stinear TP; Howden BP; Peleg AY
Clin Microbiol Infect; 2017 Oct; 23(10):767-773. PubMed ID: 28396035
[TBL] [Abstract][Full Text] [Related]
2. Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.
Howden BP; Johnson PD; Ward PB; Stinear TP; Davies JK
Antimicrob Agents Chemother; 2006 Sep; 50(9):3039-47. PubMed ID: 16940100
[TBL] [Abstract][Full Text] [Related]
3. VraR Binding to the Promoter Region of
Dai Y; Chang W; Zhao C; Peng J; Xu L; Lu H; Zhou S; Ma X
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28289032
[TBL] [Abstract][Full Text] [Related]
4. Different bacterial gene expression patterns and attenuated host immune responses are associated with the evolution of low-level vancomycin resistance during persistent methicillin-resistant Staphylococcus aureus bacteraemia.
Howden BP; Smith DJ; Mansell A; Johnson PD; Ward PB; Stinear TP; Davies JK
BMC Microbiol; 2008 Feb; 8():39. PubMed ID: 18304359
[TBL] [Abstract][Full Text] [Related]
5. Comparative Analysis of Virulence and Toxin Expression of Vancomycin-Intermediate and Vancomycin-Sensitive
Jin Y; Yu X; Zhang S; Kong X; Chen W; Luo Q; Zheng B; Xiao Y
Front Microbiol; 2020; 11():596942. PubMed ID: 33193280
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of RNAIII in vancomycin-intermediate Staphylococcus aureus strains regardless of the presence of agr mutation.
Park C; Shin NY; Byun JH; Shin HH; Kwon EY; Choi SM; Kim SH; Kwon JC; Park SH; Choi JH; Yoo JH; Yoo JI; Chung GT; Lee DG
J Med Microbiol; 2012 Mar; 61(Pt 3):345-352. PubMed ID: 22016559
[TBL] [Abstract][Full Text] [Related]
7. Modulating activity of vancomycin and daptomycin on the expression of autolysis cell-wall turnover and membrane charge genes in hVISA and VISA strains.
Cafiso V; Bertuccio T; Spina D; Purrello S; Campanile F; Di Pietro C; Purrello M; Stefani S
PLoS One; 2012; 7(1):e29573. PubMed ID: 22253738
[TBL] [Abstract][Full Text] [Related]
8. A vancomycin resistance-associated WalK(S221P) mutation attenuates the virulence of vancomycin-intermediate Staphylococcus aureus.
Rao Y; Peng H; Shang W; Hu Z; Yang Y; Tan L; Li M; Zhou R; Rao X
J Adv Res; 2022 Sep; 40():167-178. PubMed ID: 36100324
[TBL] [Abstract][Full Text] [Related]
9. The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA.
Howden BP; Peleg AY; Stinear TP
Infect Genet Evol; 2014 Jan; 21():575-82. PubMed ID: 23567819
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of amino acid changes in the yvqF, vraSR, graSR, and tcaRAB genes from vancomycin intermediate resistant Staphylococcus aureus.
Yoo JI; Kim JW; Kang GS; Kim HS; Yoo JS; Lee YS
J Microbiol; 2013 Apr; 51(2):160-5. PubMed ID: 23625215
[TBL] [Abstract][Full Text] [Related]
11. Activity of telavancin against heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) in vitro and in an in vivo mouse model of bacteraemia.
Hegde SS; Skinner R; Lewis SR; Krause KM; Blais J; Benton BM
J Antimicrob Chemother; 2010 Apr; 65(4):725-8. PubMed ID: 20139142
[TBL] [Abstract][Full Text] [Related]
12. Production of extracellular polysaccharide and biofilm under different oxygen conditions by clinical isolates of Staphylococcus aureus non-susceptible to glycopeptides.
Szymanek-Majchrzak K; Wodzyńska S; Młynarczyk A; Młynarczyk G
Przegl Epidemiol; 2018; 72(4):487-498. PubMed ID: 30810004
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic Characteristics of Vancomycin-Non-Susceptible Staphylococcus aureus.
Sirichoat A; Wongthong S; Kanyota R; Tavichakorntrakool R; Chanawong A; Welbat JU; Lulitanond A
Jundishapur J Microbiol; 2016 Jan; 9(1):e26069. PubMed ID: 27099678
[TBL] [Abstract][Full Text] [Related]
14. Candida albicans Augments Staphylococcus aureus Virulence by Engaging the Staphylococcal
Todd OA; Fidel PL; Harro JM; Hilliard JJ; Tkaczyk C; Sellman BR; Noverr MC; Peters BM
mBio; 2019 Jun; 10(3):. PubMed ID: 31164467
[No Abstract] [Full Text] [Related]
15. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.
Sakoulas G; Eliopoulos GM; Moellering RC; Wennersten C; Venkataraman L; Novick RP; Gold HS
Antimicrob Agents Chemother; 2002 May; 46(5):1492-502. PubMed ID: 11959587
[TBL] [Abstract][Full Text] [Related]
16. Is reduced vancomycin susceptibility a factor associated with poor prognosis in MSSA bacteraemia?
López-Cortés LE; Velasco C; Retamar P; del Toro MD; Gálvez-Acebal J; de Cueto M; García-Luque I; Caballero FJ; Pascual A; Rodríguez-Baño J
J Antimicrob Chemother; 2015 Sep; 70(9):2652-60. PubMed ID: 26023210
[TBL] [Abstract][Full Text] [Related]
17. Relationship between agr dysfunction and reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus causing bacteraemia.
Viedma E; Sanz F; Orellana MA; San Juan R; Aguado JM; Otero JR; Chaves F
J Antimicrob Chemother; 2014 Jan; 69(1):51-8. PubMed ID: 23975741
[TBL] [Abstract][Full Text] [Related]
18. Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR.
Howden BP; McEvoy CR; Allen DL; Chua K; Gao W; Harrison PF; Bell J; Coombs G; Bennett-Wood V; Porter JL; Robins-Browne R; Davies JK; Seemann T; Stinear TP
PLoS Pathog; 2011 Nov; 7(11):e1002359. PubMed ID: 22102812
[TBL] [Abstract][Full Text] [Related]
19. In vitro synergistic effects of various combinations of vancomycin and non-beta-lactams against Staphylococcus aureus with reduced susceptibility to vancomycin.
Kang YR; Chung DR; Kim J; Baek JY; Kim SH; Ha YE; Kang CI; Peck KR; Song JH
Diagn Microbiol Infect Dis; 2016 Nov; 86(3):293-299. PubMed ID: 27591174
[TBL] [Abstract][Full Text] [Related]
20. Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing.
Chen CJ; Lin MH; Shu JC; Lu JJ
J Antimicrob Chemother; 2014 Feb; 69(2):349-54. PubMed ID: 24092658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
